Regulation of cell migration by DDR1 was reported in various cancer cell lines including glioma (Ram et al., 2006), hepatocarcinoma (Park et al., 2007), lung (Yang et al., 2010), pancreas (Rudra-Ganguly et al., 2014), colorectal (Hu et al., 2014), and breast (Hansen et al., 2006; Huang et al., 2009; Castro-Sanchez et al., 2010; Neuhaus et al., 2011) carcinoma. This evidence concerns the gene DDR1 and central nervous system cancer.